Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.

DNA and cell biology - 1 Dec 2007

Gunes Sezgin, Bagci Hasan, Sarikaya Saban, Bilen Cenk Yucel, Kara Nurten

Abstract excerpt

We investigated the association of prostate cancer (PCa) and benign prostatic hyperplasia (BPH) with genetic polymorphisms in prostate-specific antigen (PSA) (-158 G/A) and 17-hydroxylase (CYP17) (-34 T/C) genes in a Turkish population. In this study, we investigated the distribution of these polymorphisms in 148 PCa patients, 136 BPH patients, and 102 healthy individuals as controls. The polymorphisms were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to DNA Primers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Promoter Regions, Genetic

Share to Prostate-Specific Antigen

Share to Prostatic Hyperplasia

Share to Prostatic Neoplasms

Share to Steroid 17-alpha-Hydroxylase

Share to Turkey

Source

Identifiers

PMID: 17961073
DOI: 10.1089/dna.2007.0646

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.PMID 17961073Read ↗

Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.Semantic proximity Read ↗

Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.Semantic proximity Read ↗

Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.Semantic proximity Read ↗

The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.Semantic proximity Read ↗

Genetic polymorphism in sex hormone metabolism and prostate cancer risk.Semantic proximity Read ↗

Relationship between CYP17 gene polymorphisms and risk of prostate cancer.Semantic proximity Read ↗

CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.Semantic proximity Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.Semantic proximity Read ↗

CYP17 gene polymorphism and its association in north Indian prostate cancer patients.Semantic proximity Read ↗

Benign prostatic hyperplasia genetic variants in Asians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.